Abstract
Medical advances including the neoadjuvant anti-PD-1 immunotherapy play a role in promoting clinical outcomes such as improved overall and progression-free survival probabilities. This paper considers the regression analysis of current status data with a cured subgroup in the population using a semiparametric non-mixture cure model. We propose a sieve maximum likelihood estimation for the model with the Bernstein polynomials. Moreover, an expectation–maximization (EM) algorithm is developed under the non-mixture cure model to calculate the estimators for both parametric and non-parametric components. Under some mild conditions, the asymptotic properties of the estimators are established, including the strong consistency, the convergence rate and the asymptotic normality. Simulation studies are conducted to investigate the finite sample performance of the proposed estimators. A real dataset from the tumorigenicity experiment is analysed for illustration.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
